Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Nilotinib can cause keratosis pilaris, a skin condition.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Early and accurate diagnosis is crucial for managing rare genetic disorders like this localized variant of junctional epidermolysis bullosa.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.